SECOND CHANCES

SECOND CHANCES

"So, Mr. Moore, what can the public expect from Exceva in the long run?

"Mr. Moore, how many people do you perceive will be cured using Exceva?"

"Mr. Moore, will you . . .”

I mentally shut out the words of the third reporter. At that point in time, I was about ready to keel over. My eyes had become blurry and red and they stung, but I lifted my shoulders a little higher and pasted on a smile that didn't reach my heart. "As you all know, my wife was diagnosed with womb cancer. Unfortunately, she wasn't diagnosed on time, and as a result. . ." I looked down and shook my head, valiantly trying to keep the tears which threatened to swim to the surface, at bay.

I looked back up at all the reporters that swarmed around, eagerly waiting for the rest of my words and I knew I couldn't let the water works reign free. "Exceva was meant for people who have been diagnosed with early stage cancer. It is a drug that's meant to give sustainability, but above all, restoration and comple